No, pharmacotherapy interventions provided to persons aged 17 years and younger at the time of the dispensing event do not count towards numerator 2 because there are no current FDA-approved tobacco cessation medications for persons under 18 years of age. If a person in denominator 2 is 18 years of age at the start of the measurement period and received pharmacotherapy interventions within the 180 days prior to the measurement period at 17 years of age, this person is not compliant with numerator 2.
This clarification will be included in the HEDIS Volume 2 MY 2026 Technical Update, scheduled for release on March 31, 2026.